Audit Microcv Tumor Markers Linearity Set, Model K719M-5
Multi-Analyte Controls, All Kinds (Assayed). 510(k) K082717, from Aalto Scientific, Ltd. (Carlsbad, CA). Product code JJY, class 1.
As of Nov 20, 2026, K082717 is an FDA 510(k) held by Aalto Scientific, Ltd., substantially equivalent on Oct 30, 2008 after 43 days, with no recalls tied to it in FDA's recall database.
- Review time: 43 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Auditâ„¢ MicroCVâ„¢ Tumor Markers Linearity Set consists of five levels in Human based serum. Each level contains the following analytes: Alpha fetoprotein (AFP), Carcinoembryonic antigen (CEA), CA 125, CA 15-3, Prostate specific antigen-free (free PSA), total PSA. The five levels demonstrate a linear relationship to each other for their respective analytes, reagents, and instruments.
- Audit Microcv General Chemistry Linearity SetK042318 · Aalto Scientific, Ltd. · Dec 9, 2004
- Audit MicroControls Linearity FD Tumor Markers IIK143573 · Aalto Scientific, Ltd. · Jan 16, 2015
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 17, 2008
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files